Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374438 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SAR’s which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
David C. Pryde, Martin Corless, David R. Fenwick, Helen J. Mason, Blanda C. Stammen, Peter T. Stephenson, David Ellis, David Bachelor, David Gordon, Christopher G. Barber, Anthony Wood, Donald S. Middleton, David C. Blakemore, Gemma C. Parsons,